Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Age, specific pathology tied to shorter symptom duration in rapidly progressive dementia
CHICAGO — Older age at symptom onset and select pathologies were associated with shorter symptom duration in patients with rapidly progressive dementia, according to a poster at ANA 2022.
Faster BMI decline after mild cognitive impairment diagnosis may indicate dementia
A faster decline in BMI and a lower BMI as a result may indicate the need for cognitive assessments prior to the possibility of incident dementia, per a study published in JAMA Psychiatry.
Log in or Sign up for Free to view tailored content for your specialty!
Penn State awarded $1.2M grant for Alzheimer’s detection study
A team of Penn State University researchers has been awarded a $1.2 million grant from the NIH to develop a machine learning system for the early detection of Alzheimer’s disease.
Video games shown to improve cognitive function in children
Children who played video games were shown to exhibit better cognitive function compared with those who didn’t, researchers reported in JAMA Network Open.
Dementia in older population linked to concurrent neuropathologies
CHICAGO — Alzheimer’s disease-related dementia among older adults is linked to a combination of neurodegenerative and vascular pathologies, according to a presenter at the 2022 American Neurological Association annual meeting.
Patient recruitment underway in phase 2a trial for cannabis oil dementia treatment
MediCane Health Inc. announced recruitment of the first patient for its phase 2a study designed to assess the effects of cannabis oil in adults with probable Alzheimer’s disease who have limited or no response to antipsychotic medication.
Diagnosis gap widens from symptom onset between Black, white patients
In older adults with dementia, Black patients were less likely to receive a diagnosis than white patients, with the difference increasing over 3 years following symptom onset, according to a recent study.
VIDEO: Drug developer targets neurotransmission to improve symptoms in AD
SAN DIEGO – AmyriAD Therapeutics is focusing on the upregulation of neurotransmission to improve cognition and global function in patients with Alzheimer’s disease, according to CEO Sharon L. Rogers, PhD.
VIDEO: Dementia patients without amnesia declined faster than those with amnesia
SAN DIEGO – Regardless of dementia type, patients with nonamnestic symptoms showed a faster rate of functional decline than those amnestic symptoms, according to a study presented at the Alzheimer’s Association International Conference.
Treatment with PDE5 inhibitors not associated with reduced risk for AD, dementia
Treatment with sildenafil or tadalafil was not associated with a reduced risk for incident Alzheimer’s disease and related dementia in patients with pulmonary hypertension, according to a study published in Brain Communications.